Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -21.38x is 29% above its 2-year average of -30.17x, around the middle of its 2-year range (-115.20x–19.35x).
20.82% above its 12-month average of -27.00x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -35.26x.
INTEREST COVERAGE RATIO
-21.38x
INTEREST COVERAGE RATIO AVG TTM
-27.00x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+20.82%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-3.05x
median of 295 covered companies
CURRENT VS SECTOR MEDIAN
-600.98%
vs the sector median at left
Carlsmed, Inc.
Market Cap
$415.93M
Interest Coverage Ratio
-21.38x
TTM Avg
-27.00x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.68M
Interest Coverage Ratio
N/A
TTM Avg
4.06x
3Y Avg
4.06x
5Y Avg
4.06x
Market Cap
$410.54M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$408.21M
Interest Coverage Ratio
-404.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$406.47M
Interest Coverage Ratio
-375.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$428.16M
Interest Coverage Ratio
-16.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$447.43M
Interest Coverage Ratio
-35.51x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$450.64M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$453.70M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Carlsmed, Inc. (CARL) | $415.93M | -21.38x | -27.00x | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | N/A | 4.06x | 4.06x | 4.06x |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $410.54M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | -404.95x | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | -375.67x | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | -16.10x | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | -35.51x | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | N/A | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $373.40M | -1.91x | N/A | N/A | N/A |
Interest Coverage
-21.4x
Debt/Equity
0.26
Current Ratio
8.84
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -35.26x |
| 2026-03-31 | -29.83x |
| 2025-12-31 | -28.24x |
| 2025-09-30 | -23.78x |
| 2025-06-30 | -17.91x |
| 2025-03-31 | -16.02x |
| 2024-12-31 | -115.20x |
| 2024-09-30 | 19.35x |
| 2024-03-31 | -24.67x |
